Keishibukuryogan (Japanese Herbal Supplement) for the Adjunctive Treatment of Catamenial Epilepsy in Adult: Safety Study.
Phase of Trial: Phase II
Latest Information Update: 27 Feb 2017
At a glance
- Drugs TJ 25 (Primary)
- Indications Catamenial seizures
- Focus Adverse reactions; Therapeutic Use
- 25 Feb 2011 New trial record